Connection

MALCOLM BRENNER to Cell Transplantation

This is a "connection" page, showing publications MALCOLM BRENNER has written about Cell Transplantation.
Connection Strength

0.341
  1. Improving the safety of T-Cell therapies using an inducible caspase-9 gene. Exp Hematol. 2016 Nov; 44(11):1013-1019.
    View in: PubMed
    Score: 0.127
  2. Developing T-cell therapies for cancer in an academic setting. Adv Exp Med Biol. 2008; 610:88-99.
    View in: PubMed
    Score: 0.070
  3. "The end of the beginning": molecular and cellular biology of gene therapy keystone. 14-20 January 1999. Biochim Biophys Acta. 1999 Jul 29; 1424(1):R5-9.
    View in: PubMed
    Score: 0.039
  4. Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene. Life Sci. 1999; 65(5):483-91.
    View in: PubMed
    Score: 0.037
  5. Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma. Hum Gene Ther. 1998 Jun 10; 9(9):1303-11.
    View in: PubMed
    Score: 0.036
  6. Gene marking. Hum Gene Ther. 1996 Oct 20; 7(16):1927-36.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.